Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
NCT07693452Phase 2Recruiting
- Sponsor
- University of California, Irvine
- Start
- Jun 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in pseudomyxoma peritonei (PMP), sponsored by University of California, Irvine. Started Jun 2026; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
pseudomyxoma peritonei (PMP)
Beyond the preview
Go deeper on NCT07693452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07693452.